Diabetes News

Using a pod-based automated insulin delivery system can provide glycemic benefits for people with type 2 diabetes, according to a speaker at the International Conference on Advanced Technologies & Treatments for Diabetes.

A slew of new medications currently in development may allow health care providers to go beyond glycemic management in the treatment of type 2 diabetes, according to a speaker.

The FDA cleared for marketing an over-the-counter continuous glucose monitor for adults with or without diabetes, according to an agency press release.

Among pregnant women with type 1 diabetes, more time in optimal glucose range at 12 weeks gestation was associated with lower risks for preeclampsia and large for gestational age infants, researchers reported.

Adults with osteoporosis who received a full course of denosumab were less likely to develop incident diabetes than those who discontinued denosumab after the initial dose, according to study data published in JAMA Network Open.

Shorter sleep durations increased the risk for developing type 2 diabetes, even among those with healthy eating habits, research showed.

Adults with type 2 diabetes and chronic kidney disease have a 24% lower risk for kidney disease progression and cardiovascular and kidney mortality with once-weekly semaglutide 1 mg, according to topline results from the FLOW trial.

Men who had a lower birth weight followed by overweight during young adulthood have a greatly increased risk for developing type 2 diabetes vs. those with normal weight at those times, according to study results published in Diabetologia.

The FDA said it will permit the use of two limited health claims that eating yogurt may reduce the risk for type 2 diabetes, according to a press release.

Testosterone replacement therapy alone did not lower risk for progression from prediabetes to diabetes or increase the likelihood of type 2 diabetes remission among men with hypogonadism, according to study data.